Covadonga M. Díaz‐Caneja

Author

Hospital General Universitario Gregorio Marañón ORCID

Also Known As

Arango, Celso, C M Diaz-Caneja, C. Diaz-Caneja, C. Díaz-Caneja, C. M Díaz-Caneja, C. M. Diaz-Caneja, C. M. Díaz-Caneja, C. M. Díaz‐Caneja, C. M. Díaz‑Caneja, C. Martinez Diaz-Caneja

284

Publications

8.7K

Citations

H-Index

119

Concepts

All Affiliations

Hospital General Universitario Gregorio Marañón Centro de Investigación Biomédica en Red de Salud Mental King's College London Universitat de Barcelona Consorci Institut D'Investigacions Biomediques August Pi I Sunyer

About

Covadonga M. Díaz‐Caneja is an author at Hospital General Universitario Gregorio Marañón specializing in medicine, psychiatry, and psychopathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	33	1.1K
2	Social Sciences	18	24	828
3	Public Health	5	5	212
4	Health Sciences	2	2	70
5	Education	1	1	19

Covadonga M. Díaz‐Caneja

Publications

Citations

H-Index

Page 1

	Year	Citations
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study Marta Di Forti, Diego Quattrone, Tom P. Freeman, The Lancet Psychiatry	2019	807
Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group Sinéad Kelly, Neda Jahanshad, Andrew Zalesky, Molecular Psychiatry	2017	706
Increased power by harmonizing structural MRI site differences with the ComBat batch adjustment method in ENIGMA Joaquim Raduà, Eduard Vieta, Russell T. Shinohara, NeuroImage	2020	256
Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study René S. Kahn, Inge Winter van Rossum, Stefan Leucht, The Lancet Psychiatry First-episode SchizophreniaPsychiatryPsychotic DisorderMedicinePsychotropic Medication	2018	190
Physical and mental health impact of COVID-19 on children, adolescents, and their families: The Collaborative Outcomes study on Health and Functioning during Infection Times - Children and Adolescents (COH-FIT-C&A) Marco Solmi, Andrés Estradé, Trevor Thompson, Journal of Affective Disorders Adolescent Behavioral HealthMental HealthCovid-19 EpidemiologySocial Determinants Of HealthCovid-19	2021	79
Towards Precision Medicine in Psychosis: Benefits and Challenges of Multimodal Multicenter Studies—PSYSCAN: Translating Neuroimaging Findings From Research into Clinical Practice Stefania Tognin, Hendrika H. van Hell, Kate Merritt, Schizophrenia Bulletin Multimodal Multicenter Studies—psyscanPsychosis OnsetNeurophysiological BiomarkersNeuropsychiatryTowards Precision Medicine	2019	77
Large-scale analysis of structural brain asymmetries in schizophrenia via the ENIGMA consortium Dick Schijven, Merel C. Postema, Masaki Fukunaga, Proceedings of the National Academy of Sciences	2023	76
Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study Emanuela Martinuzzi, Susana Barbosa, Douglas Daoudlarian, Translational Psychiatry	2019	73
Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis Miquel Bioque, María Paz García‐Portilla, Clemente García‐Rizo, Schizophrenia Research PsychopathologyRisk PredictionPsychiatryMetabolic Risk FactorsFirst Episodes	2017	69
The Association Between Comorbid Autism Spectrum Disorders and Antipsychotic Treatment Failure in Early-Onset Psychosis Johnny Downs, Suzannah Lechler, Harry Dean, The Journal of Clinical Psychiatry	2017	67

Page 1